We all know that heart disease is the leading killer in America. High cholesterol also leads to strokes and peripheral vascular disease. When they came on the scene decades ago, statins were a game changer. Now there is a new and exciting breakthrough drug when it comes to fighting cholesterol. These new drugs are expected to receive FDA approval sometime this summer.
These new drugs are known as PCSK9 inhibitors. These new injectable antibodies will limit the production of LDL – the bad cholesterol. Two recent studies found that these new drugs reduced bad cholesterol by as much as 60%. This would greatly lower a persons chance of developing a stroke or heart attack.